In Vitro Diagnostic (IVD) In Cardiology And Neurology Global Market Report 2025
상품코드:1825773
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
심장학 및 신경학 체외진단(IVD) 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR) 8.2%로 235억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 순환기내과 및 신경과에서 맞춤형 의료로의 전환, 순환기내과 및 신경과에서 신속한 현장 검사 솔루션에 대한 수요 증가, 원격의료 및 원격진료 서비스 확대, 연구 이니셔티브 증가에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 액체 생검 기술의 출현, 나노기술의 발전, 이식형 심장 모니터 및 뇌-컴퓨터 인터페이스와 같은 원격 모니터링 장비의 채택, 다중 바이오마커 패널의 사용, MRI, CT, PET 스캔, MRI, CT, PET 스캔과 같은 의료 영상 진단 기법의 혁신 등 의료용 영상 진단 양식의 혁신, 심혈관 및 신경계 약물의 동반진단약물 개발 등을 들 수 있습니다.
향후 5년간 8.2%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 스웨덴과 벨기에에서 개발된 체외진단용 의약품의 가격을 급등시켜 뇌졸중과 심장마비 진단을 지연시키고 응급의료비를 증가시킴으로써 신속 트로포닌 검사와 아밀로이드 베타 검사의 미국 내 채택을 방해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
맞춤형 의료의 확대는 당분간 순환기내과와 신경과 체외진단약(IVD) 시장의 발전을 견인할 것으로 보입니다. 맞춤형 의료는 환자 개개인의 특성에 따라 의료 개입과 치료를 맞춤화하는 것으로, 유전체 분석의 발전, 질병 메커니즘에 대한 이해의 향상, 맞춤형 치료에 대한 환자 수요, 규제 당국의 지원 등의 요인으로 인해 더욱 탄력을 받고 있습니다. 심장학 및 신경학에서 체외진단용 의약품(IVD) 검사는 개인의 유전적 구성과 질병 상태에 대한 중요한 인사이트를 제공함으로써 맞춤형 의료를 촉진하는 데 매우 중요한 역할을 하고 있습니다. 이러한 인사이트는 맞춤형 치료 전략의 개발로 이어져 효능을 높이고 위험을 최소화할 수 있는 맞춤형 치료 전략을 개발할 수 있습니다. 예를 들어, 개인맞춤의료연합(Personalized Medicine Coalition)의 데이터에 따르면, 2022년에는 새로 승인된 치료법의 약 34%가 개인맞춤의료로, 이전보다 크게 증가할 것으로 예상하고 있습니다. 따라서 맞춤형 의약품의 채택이 확대되면서 심장학 및 신경학 체외진단(IVD) 시장의 성장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 심장학 및 신경학 체외진단(IVD) : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 성장률 분석
세계의 심장학 및 신경학 체외진단(IVD) 시장 실적 : 규모와 성장, 2019-2024
세계의 심장학 및 신경학 체외진단(IVD) 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 심장학 및 신경학 체외진단(IVD) : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
기기
시약 및 소모품
소프트웨어와 서비스
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
면역측정
분자진단
혈액학
기타 기술
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
임상 검사실
기타 최종사용자
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 하위 세분화 기기 : 진단 분석기(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
POC(Point of Care) 디바이스
전기생리학 디바이스
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 하위 세분화 시약 및 소모품(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단 시약
검사 키트
어세이 소모품
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 하위 세분화 소프트웨어와 서비스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
진단 소프트웨어
데이터 관리 소프트웨어
IVD 컨설팅 및 서포트 서비스
제7장 지역별·국가별 분석
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 심장학 및 신경학 체외진단(IVD) 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
심장학 및 신경학 체외진단(IVD) 시장 : 경쟁 구도
심장학 및 신경학 체외진단(IVD) 시장 : 기업 개요
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Becton Dickinson And Company
Quest Diagnostics Incorporated
Hologic Inc.
Illumina Inc.
Beckman Coulter Inc.
Quidel Corporation
Sysmex Corporation
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Instrumentation Laboratory
bioMerieux SA
Natera, Inc.
Randox Laboratories Ltd.
Fulgent Genetics Inc.
DiaSorin S.p.A.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
심장학 및 신경학 체외진단(IVD) 시장 2029 : 새로운 기회를 제공하는 국가
심장학 및 신경학 체외진단(IVD) 시장 2029 : 새로운 기회를 제공하는 부문
심장학 및 신경학 체외진단(IVD) 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
In vitro diagnostic (IVD) in cardiology and neurology involves conducting medical tests on samples such as blood, urine, or tissue outside the body to diagnose a range of cardiovascular and neurological ailments. These tests are pivotal for detecting conditions such as heart disease, stroke, Alzheimer's disease, and more, aiding in early diagnosis, ongoing monitoring, and treatment planning. They offer timely diagnostic insights crucial for guiding patient care and enhancing outcomes in both cardiology and neurology.
The main products of in vitro diagnostic (IVD) in cardiology and neurology encompass instruments, reagents and consumables, and software and services. Instruments denote the tools or apparatuses utilized for conducting diagnostic examinations and scrutinizing patient specimens within laboratory environments. These encompass various technologies such as immunoassays, molecular diagnostics, and hematology, catering to the needs of hospitals, clinical laboratories, and similar entities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The in vitro diagnostic (IVD) in cardiology and neurology market research report is one of a series of new reports from The Business Research Company that provides in vitro diagnostic (IVD) in cardiology and neurology market statistics, including the in vitro diagnostic (IVD) in cardiology and neurology industry global market size, regional shares, competitors with in vitro diagnostic (IVD) in cardiology and neurology market share, detailed in vitro diagnostic (IVD) in cardiology and neurology market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro diagnostic (IVD) in cardiology and neurology industry. This in vitro diagnostic (IVD) in cardiology and neurology market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The in vitro diagnostic (ivd) in cardiology and neurology market size has grown strongly in recent years. It will grow from $15.84 billion in 2024 to $17.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rise in the prevalence of age-related cardiovascular and neurological disorders, rise in the aging population, growing emphasis on preventive healthcare and early disease detection, the increasing burden of cardiovascular diseases (CVDs) and neurological disorders, such as stroke and Alzheimer's disease, rise in investments in healthcare infrastructure, and rise in supportive regulatory frameworks governing the approval and reimbursement of diagnostic tests.
The in vitro diagnostic (ivd) in cardiology and neurology market size is expected to see strong growth in the next few years. It will grow to $23.59 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to the shift towards personalized medicine in cardiology and neurology, increasing demand for rapid and on-site testing solutions in cardiology and neurology, expansion of telemedicine and remote consultation services, and rise in research initiatives. Major trends in the forecast period include emergence of liquid biopsy technologies, advancements in nanotechnology, adoption of remote monitoring devices, such as implantable cardiac monitors and brain-computer interfaces, use of multiplex biomarker panels, innovations in medical imaging modalities, such as MRI, CT, and PET scans, and development of companion diagnostics for cardiovascular and neurological drugs.
The forecast of 8.2% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of rapid troponin and amyloid beta tests by inflating prices of IVD assays developed in Sweden and Belgium, resulting in delayed stroke and heart attack diagnoses and higher emergency care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The expansion of personalized medicine is poised to drive the advancement of the in vitro diagnostic (IVD) market in cardiology and neurology in the foreseeable future. Personalized medicine, which customizes healthcare interventions and treatments to suit the unique characteristics of individual patients, is gaining momentum due to progress in genomics, enhanced understanding of disease mechanisms, patient demand for tailored therapies, and regulatory backing, among other factors. In cardiology and neurology, IVD tests play a pivotal role in facilitating personalized medicine by furnishing essential insights into an individual's genetic composition and disease status. These insights guide the development of customized treatment strategies, thereby enhancing efficacy and minimizing risks. For instance, data from the Personalized Medicine Coalition indicates that in 2022, approximately 34% of all newly approved therapies were personalized medicines, marking a significant rise from previous years. Hence, the escalating adoption of personalized medicines is propelling the growth of the in vitro diagnostic (IVD) market in cardiology and neurology.
Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are innovating AI-driven integrated epigenetic systems to enable early detection of diseases and assess risks. These AI-enabled integrated epigenetic systems utilize machine learning and advanced biomarker analysis methods to improve the precision and sensitivity of diagnosing and monitoring cardiovascular conditions, thereby targeting key factors influencing disease advancement. For example, in February 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology firm, introduced PrecisionCHD, an AI-powered blood test engineered for the timely identification of coronary heart disease (CHD). Employing the company's integrated epigenetic-genetic engine, this test evaluates CHD susceptibility and strives to preemptively detect the most prevalent cardiovascular ailment. Combining epigenetic and genetic indicators with machine learning algorithms, the new test delivers over 75% sensitivity for both genders. It establishes a connection between a patient's biomarker profile and modifiable risk elements, such as smoking, diabetes, hypertension, and elevated cholesterol levels, which significantly contribute to CHD. PrecisionCHD presents a non-invasive option to conventional methods such as exercise stress tests or angiograms, as it requires blood samples collected either at the clinic or home.
In March 2024, Beckman Coulter, a US-based company specializing in laboratory diagnostics, expanded its partnership with Fujirebio to focus on the development, manufacturing, and clinical adoption of neurodegenerative disease assays. This collaboration aims to combine their expertise in laboratory diagnostics and neurological markers to advance the development of innovative assays for diagnosing neurodegenerative diseases, ultimately improving patient outcomes through more accurate and timely diagnostics. Fujirebio, a Japan-based company, specializes in in vitro diagnostics (IVD) in cardiology and neurology.
Major companies operating in the in vitro diagnostic (IVD) in cardiology and neurology market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostics Incorporated, Hologic Inc., Illumina Inc., Beckman Coulter Inc., Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Instrumentation Laboratory, bioMerieux SA, Natera, Inc., Randox Laboratories Ltd., Fulgent Genetics Inc., DiaSorin S.p.A., Oxford Nanopore Technologies, Fujirebio Diagnostics Inc., Adaptive Biotechnologies, Biocartis Group NV, Agena Bioscience
North America was the largest region in the in vitro diagnostic (IVD) in cardiology and neurology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the in vitro diagnostic (IVD) in cardiology and neurology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The in vitro diagnostic (IVD) in cardiology and neurology market consists of revenues earned by entities by providing services such as point-of-care testing, laboratory testing, molecular diagnostics, and biomarker testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
In Vitro Diagnostic (IVD) In Cardiology And Neurology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on in vitro diagnostic (ivd) in cardiology and neurology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for in vitro diagnostic (ivd) in cardiology and neurology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in vitro diagnostic (ivd) in cardiology and neurology market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Instruments; Reagents And Consumables; Software And Services
2) By Technology: Immunoassays; Molecular Diagnostics; Hematology; Other Technologies
3) By End-User: Hospitals; Clinical Laboratories; Other End-Users
Subsegments:
1) By Instruments: Diagnostic Analyzers; Point-Of-Care Devices; Electrophysiology Devices
2) By Reagents And Consumables: Diagnostic Reagents; Test Kits; Assay Consumables
3) By Software And Services: Diagnostic Software; Data Management Software; IVD Consulting And Support Services
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Characteristics
3. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Trends And Strategies
4. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Growth Analysis And Strategic Analysis Framework
5.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Growth Rate Analysis
5.4. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Total Addressable Market (TAM)
6. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Segmentation
6.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Instruments
Reagents And Consumables
Software And Services
6.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunoassays
Molecular Diagnostics
Hematology
Other Technologies
6.3. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinical Laboratories
Other End-Users
6.4. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Instruments: Diagnostic Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Point-Of-Care Devices
Electrophysiology Devices
6.5. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Reagents
Test Kits
Assay Consumables
6.6. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Software
Data Management Software
IVD Consulting And Support Services
7. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Regional And Country Analysis
7.1. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
8.1. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
9.1. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
9.2. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
10.1. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
11.1. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
11.2. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
12.1. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
13.1. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
14.1. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
14.2. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
15.1. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
15.2. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
16.1. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
17.1. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
18.1. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
19.1. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
20.1. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
21.1. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
21.2. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
22.1. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
23.1. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
23.2. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
24.1. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
24.2. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
25.1. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
25.2. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
26.1. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
26.2. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
27.1. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
28.1. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
28.2. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
29.1. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Overview
29.2. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa In Vitro Diagnostic (IVD) In Cardiology And Neurology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape And Company Profiles
30.1. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Landscape
30.2. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
31. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Other Major And Innovative Companies
31.1. Becton Dickinson And Company
31.2. Quest Diagnostics Incorporated
31.3. Hologic Inc.
31.4. Illumina Inc.
31.5. Beckman Coulter Inc.
31.6. Quidel Corporation
31.7. Sysmex Corporation
31.8. Bio-Rad Laboratories Inc.
31.9. QIAGEN N.V.
31.10. Instrumentation Laboratory
31.11. bioMerieux SA
31.12. Natera, Inc.
31.13. Randox Laboratories Ltd.
31.14. Fulgent Genetics Inc.
31.15. DiaSorin S.p.A.
32. Global In Vitro Diagnostic (IVD) In Cardiology And Neurology Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
34. Recent Developments In The In Vitro Diagnostic (IVD) In Cardiology And Neurology Market
35. In Vitro Diagnostic (IVD) In Cardiology And Neurology Market High Potential Countries, Segments and Strategies
35.1 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Countries Offering Most New Opportunities
35.2 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Segments Offering Most New Opportunities
35.3 In Vitro Diagnostic (IVD) In Cardiology And Neurology Market In 2029 - Growth Strategies
